A Phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer
The official starting dose won't be confirmed until approval, but 2mg is most likely based on trial data, as it balances effectiveness with tolerability
Engineered nanomedicine for myeloma and bone microenvironment targeting
Prophecys expertise area covers products, services, latest trends, developments, market growth factors, and challenges along with market forecasts in various business areas such as Healthcare, Pharmaceutical, Biotechnology, Information Technology (IT), Automotive, Industrial, Chemical, Agriculture, Food and Beverage, Energy, and Oil and Gas
This action may improve insulin sensitivity and promote glucose uptake in cells, similar to some aspects of metformin's mechanism
Many people find that combining a healthy diet with a liposomal supplement provides more consistent results for cellular health.